Literature DB >> 24329867

Does enamel matrix derivative application provide additional clinical benefits in residual periodontal pockets associated with suprabony defects? A systematic review and meta-analysis of randomized clinical trials.

Filippo Graziani1, Stefano Gennai, Silvia Cei, Francesco Ducci, Nicola Discepoli, Alessandro Carmignani, Maurizio Tonetti.   

Abstract

OBJECTIVE: To review the effectiveness of enamel matrix derivative (EMD) in the treatment of periodontal pockets of suprabony defects.
METHODS: Randomized Clinical Trials comparing open flap debridement (OFD) versus EMD in periodontal suprabony defects were identified through electronic and manual search. Screening, data extraction and quality assessment were conducted. The primary outcome measures were tooth survival (TS) and clinical attachment level (CAL) gain. Pocket probing depth (PPD) reduction and recession (REC) increase were secondary outcome measures. Information concerning clinical and radiological bone gain was also collected.
RESULTS: The search identified 1170 studies, three articles reporting on (99 subjects/358 teeth) met the inclusion criteria and were included. No tooth was lost during follow-up (8-12 months). The adjunctive mean benefit of EMD was: 1.2 mm for CAL gain [confidence interval (CI): (0.9, 1.4), p < 0.00001, I(2) = 66%], 1.2 mm for the PPD reduction (CI: [0.8, 1.5], p < 0.0001, I(2) = 0%), -0.5 mm for the REC increase (CI: [-0.8, -0.2], p = 0.003, I(2) = 0%). Potential risk of bias was identified.
CONCLUSIONS: No differences were noted in TS but EMD application resulted in clinical and radiographic additional benefits compared to OFD alone. Nevertheless, the paucity of data, the risk of methodological and potential publication bias suggests caution in interpreting these results while supporting multicenter studies for this specific application.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  access flap; amelogenins; enamel matrix derivatives; meta-analysis; suprabony defects

Mesh:

Substances:

Year:  2014        PMID: 24329867     DOI: 10.1111/jcpe.12218

Source DB:  PubMed          Journal:  J Clin Periodontol        ISSN: 0303-6979            Impact factor:   8.728


  4 in total

1.  Root coverage with tunneling technique or modified advanced flap associated with acellular dermal matrix: results from 6 months randomized clinical trial.

Authors:  Umberto D Ramos; Gabriel F Bastos; Camila A Costa; Sergio L S de Souza; Mario Taba; Arthur B Novaes
Journal:  Clin Oral Investig       Date:  2021-08-07       Impact factor: 3.573

Review 2.  Enamel matrix derivative as adjunctive to non-surgical periodontal therapy: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Andrea Roccuzzo; Jean-Claude Imber; Alexandra Stähli; Dimitrios Kloukos; Giovanni E Salvi; Anton Sculean
Journal:  Clin Oral Investig       Date:  2022-04-07       Impact factor: 3.606

Review 3.  The Effect of Diabetes Mellitus on IGF Axis and Stem Cell Mediated Regeneration of the Periodontium.

Authors:  Nancy M S Hussein; Josie L Meade; Hemant Pandit; Elena Jones; Reem El-Gendy
Journal:  Bioengineering (Basel)       Date:  2021-12-03

4.  Single flap approach with or without enamel matrix derivative in the treatment of severe supraosseous defects: a retrospective study.

Authors:  Anna Simonelli; Luigi Minenna; Leonardo Trombelli; Roberto Farina
Journal:  Clin Oral Investig       Date:  2021-04-14       Impact factor: 3.573

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.